Seeking Alpha

NPS Pharmaceuticals (NPSP +04%) says the FDA has approved Gattex for the treatment of adult...

NPS Pharmaceuticals (NPSP +04%) says the FDA has approved Gattex for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. The company says Gattex will be available in Q113.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)